Skip to main content
. Author manuscript; available in PMC: 2013 Nov 13.
Published in final edited form as: J Clin Cell Immunol. 2011 Nov 15;Suppl 1:003. doi: 10.4172/2155-9899.S1-003

Figure 4. TGF-β1 inhibits Akt phosphorylation induced by IL-5 signaling.

Figure 4

(A) 72 hr viability of PBEos left untreated (0), treated as shown with or without SB431542 (SB). (B, C and D) Immunoblots of PBEos treated with SB, LY294002 (LY) or Akt Inhibitor IV (AktI). (E) and (F) Viability of PBEos treated as shown and presented as a percentage of viability at time 0. **, p< 0.03 (one-way ANOVA). All blots are representative of at least 3 independent experiments with different donors and data are expressed as the mean ± SEM.